Novartis India Limited (BOM:500672)
India · Delayed Price · Currency is INR 830.85
+0.45 (0.05%)
At close: Feb 12, 2026
Novartis India Market Cap
Novartis India has a market cap or net worth of 20.51 billion as of February 13, 2026. Its market cap has decreased by -8.20% in one year.
Market Cap
20.51B
Enterprise Value
14.38B
Revenue
3.48B
Ranking
n/a
PE Ratio
21.10
Stock Price
830.85
Market Cap Chart
Since April 14, 1999, Novartis India's market cap has increased from 12.59B to 20.51B, an increase of 63.00%. That is a compound annual growth rate of 1.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 20.51B | 6.66% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 31.33B |
| Unichem Laboratories | 27.17B |
| Hikal | 22.74B |
| Bliss GVS Pharma | 21.94B |
| Morepen Laboratories | 21.66B |
| Shukra Pharmaceuticals | 19.52B |
| Amrutanjan Health Care | 18.28B |
| Syncom Formulations (India) | 13.48B |